New salmeterol/fluticasone MDI extends choice in asthma prescribing

by Lisa Lytle on the 5 October 2017

Aloflute (salmeterol/fluticasone) metered dose inhaler is licensed for the treatment of asthma where use of a combination product is appropriate.

To continue reading you need to be a registered user or subscriber

Existing users login here

Forgotten Password?

Need help? Email us

Not registered? Sign up now for FREE access to:

  • GP online

Registered GPs also have FREE access to:

  • MIMS online
  • MIMS print*

Sign up now

Want access to MIMS and not a GP?

Subscribe to MIMS today

*Fully qualified GPs based in NHS practices only. All other GPs can access MIMS in print by subscription